drugset / Trial / NCT02604576

Efficacy of Bromopride and Simethicone Versus Bromopride in Functional Dyspepsia

NCT02604576

Phase 3 Completed 339 enrolled EMS
RandomizedParallel-groupTriple-blindTreatment

Summary

Multi-center, randomized, superiority, double blind clinical trial to asses the efficacy of fixed-dose combination of bromopride and simethicone versus isolated bromopride on research participants diagnosed with functional dyspepsia.

Timeline

Start
2017-01-17
Primary completion
2018-03-13
Completion
2019-03-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Bromopride Small molecule 10 mg
Subject Simethicone Other / unclassified 80 mg

Indications